Rudin Glaucoma Prize winner announced

Article

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012.

The professor of ophthalmology at Duke Eye Centre, Duke University School of Medicine, Durham, North Carolina, USA, was selected by the New York Academy of Medicine to receive the prize this year. He was presented with the award for his insightful research on fostering a greater understanding of glaucoma.

Dr David Abramson, Chair of the Lewis Rudin Prize Selection Committee and Chief of Ophthalmic Oncology at Memorial Sloan-Kettering Cancer Centre, said, "Dr Stamer's discovery of a previously unrecognized signalling molecule that is important in normal and glaucoma eyes (nitrous oxide synthase) opens entirely new areas for research and treatment of the most common glaucomas worldwide."

Additionally, Dr Stamer is Editor-in-Chief of the Journal of Ocular Pharmacology & Therapeutics and is a member of the editorial boards for Investigative Ophthalmology and Visual Science and Experimental Eye Research.

For more information on the Lewis Rudin Glaucoma Prize please visit the official webpage.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.